3RAJAKUMAR A, MICHAEL H M, RAJUKUMAR P A, et al. Extraplacental, expression of vascular endothelial growth factor receptor-1, (Flt-1)and soluble Fit-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs)in normotensive and preeclamptic pregnant women[J]. Placenta, 2005,26 (7):563-273.
4WITTE L, HICKLIN D J, ZHU Z,et al. Monoclonal antibodies targeting the VEGF receptor-2(FLK-1/KDR)as an anti-angiogenic therapeutic stratagy [J].Cancer Metastasis Rev, 1998, 17 (2) : 155-159.
5HANAHAN J,FOLKMEN J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis [J]. Cell, 1996,86 (3) :353-364.
7BROEKELSY J, HAYMAN R, AHMED A, et al. VEGF via VEGF receptor-1 (Fit-1) mimic preaclamplic plasma in inhibiting uterine blood vessel relaxation in pregnancy: implications in the pathogesis of preeclampsia [J]. Lab Invest, 1999, 79 (9):1101- 1111.
5Mattei MG, Brog JP, Rosnet O, et al. Assignment of vascular endothelial growth factor (VEGF) and placenta growth factor (P1GF)genes to human chromosome 6p12 - 6p21 and 14o.24 - 14q31 regions, respectively. Genmics, 1996;32:168-- 169.
6Khaliq A, Dunk C,Jiang JQ, et al. Hypoxia down - regulates placenta growth factor, whereas fetal growth restriction up - regulates placenta growth factor expression: molecular evidence for "placenta hypoxia" in intrauterine growth restriction. Lab Inves, 1999; 79(2):151 ~170.
7Kurz H, Wilting J, Sandan K, et al. Automated evaluation of angiogenie effects mediated by VEGF and P1GF hc~ao - and heterodimer. Microvase Res, 1998;55( 1 ) :92 -- 102.
8Nanaev A, Chwalisz K, Frank It, et al. Physiological dilation of uteroplacental arteries in the guinea pig depends on nitric oxide synthase activity of extro villous trophoblast. Cell Tissue Res, 1995;282: 407 -- 421.
9Rutherford RAD, McCarthy A, Sullivan MHF, et al. Nitric oxide synthase in human placenta and umbilical cord form normal, intrauterine growth - retarded and pre - eclamptic pregnancies. Br J Pharmacol, 1995; 116:3099--3109.
10Torry D S, Wang H S, Wang T H, et al. Preeclampsia is associated with reduced serum levels of placenta growth factor. Am J Obstet Gyneeol, 1998; 179(6Ptl) : 1539-- 1544.
